Spectral Medical Inc.
EDTXF
Rank in Stocks
#16163
Spectral Medical Inc. focuses on the development and commercialization of... Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Share Price
$0.77099
Last synced: 2026-11-09
Market Cap
$224.51M
Change (1 day)
12.88%
Change (1 year)
-28.61%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Spectral Medical Inc. (EDTXF)
Category
Healthcare
Operating Margin for Spectral Medical Inc. (EDTXF)
Operating Margin as of November 2026 TTM: -431.14%
According to Spectral Medical Inc.'s latest financial reports, its current operating margin (TTM) is -431.14%. At the end of 2025 the company had an operating margin of -478.50%.
Operating Margin history for Spectral Medical Inc. from 2001 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -431.14% | -9.90% |
| 2025 | -478.50% | -8.82% |
| 2024 | -524.80% | -26.57% |
| 2023 | -714.71% | 41.05% |
| 2022 | -506.72% | 51.93% |
| 2021 | -333.52% | -21.63% |
| 2020 | -425.56% | 156.25% |
| 2019 | -166.07% | 174.04% |
| 2018 | -60.60% | -43.55% |
| 2017 | -107.36% | -62.75% |
| 2016 | -288.21% | -7.33% |
| 2015 | -311.01% | -9.28% |
| 2014 | -342.81% | -19.58% |
| 2013 | -426.27% | 28.12% |
| 2012 | -332.72% | 19.28% |
| 2011 | -278.93% | 33.03% |
| 2010 | -209.68% | 167.65% |
| 2009 | -78.34% | 41.59% |
| 2008 | -55.33% | -3.99% |
| 2007 | -57.63% | -18.93% |
| 2006 | -71.09% | 24.87% |
| 2005 | -56.93% | 21.93% |
| 2004 | -46.69% | 47.29% |
| 2003 | -31.70% | 26.19% |
| 2002 | -25.12% | -49.93% |
| 2001 | -50.17% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -100.04% |
US
|
|
| 20.38% | -100.05% |
US
|
|
| 43.02% | -100.10% |
CN
|
|
| 32.03% | -100.07% |
US
|
|
| 22.23% | -100.05% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Spectral Medical Inc.'s operating margin
What is Spectral Medical Inc.'s operating margin?
Spectral Medical Inc.'s operating margin is -431.14%, as of Nov 2026.
What was Spectral Medical Inc.'s operating margin in 2025?
In 2025, Spectral Medical Inc.'s operating margin was -478.50%, compared with -524.80% in 2024.
How has Spectral Medical Inc.'s operating margin changed since 2020?
From 2020 to 2025, Spectral Medical Inc.'s operating margin was highest in 2021 (-333.52%) and lowest in 2023 (-714.71%).
How does Spectral Medical Inc.'s operating margin compare with similar companies?
Spectral Medical Inc.'s operating margin (-431.14%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.